A new mutational hotspot in the SKI gene in the context of MFS/TAA molecular diagnosis.


Journal

Human genetics
ISSN: 1432-1203
Titre abrégé: Hum Genet
Pays: Germany
ID NLM: 7613873

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 02 10 2019
accepted: 10 12 2019
pubmed: 26 1 2020
medline: 26 3 2020
entrez: 26 1 2020
Statut: ppublish

Résumé

SKI pathogenic variations are associated with Shprintzen-Goldberg Syndrome (SGS), a rare systemic connective tissue disorder characterized by craniofacial, skeletal and cardiovascular features. So far, the clinical description, including intellectual disability, has been relatively homogeneous, and the known pathogenic variations were located in two different hotspots of the SKI gene. In the course of diagnosing Marfan syndrome and related disorders, we identified nine sporadic probands (aged 2-47 years) carrying three different likely pathogenic or pathogenic variants in the SKI gene affecting the same amino acid (Thr180). Seven of these molecular events were confirmed de novo. All probands displayed a milder morphological phenotype with a marfanoid habitus that did not initially lead to a clinical diagnosis of SGS. Only three of them had learning disorders, and none had intellectual disability. Six out of nine presented thoracic aortic aneurysm, which led to preventive surgery in the oldest case. This report extends the phenotypic spectrum of variants identified in the SKI gene. We describe a new mutational hotspot associated with a marfanoid syndrome with no intellectual disability. Cardiovascular involvement was confirmed in a significant number of cases, highlighting the importance of accurately diagnosing SGS and ensuring appropriate medical treatment and follow-up.

Identifiants

pubmed: 31980905
doi: 10.1007/s00439-019-02102-9
pii: 10.1007/s00439-019-02102-9
doi:

Substances chimiques

DNA-Binding Proteins 0
Proto-Oncogene Proteins 0
SKI protein, human 126648-96-2

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

461-472

Subventions

Organisme : Conseil régional de Bourgogne-Franche-Comté
ID : Plan d'Actions Régional pour l'Innovation (PARI 2015)
Organisme : Conseil régional de Bourgogne-Franche-Comté
ID : European Union through the PO FEDER-FSE Bourgogne 2014/2020 programs.

Références

N Engl J Med. 2006 Aug 24;355(8):788-98
pubmed: 16928994
J Biol Chem. 2003 Jul 11;278(28):26249-57
pubmed: 12732634
Neuron. 2004 Aug 19;43(4):499-511
pubmed: 15312649
Hum Mutat. 2016 Jun;37(6):564-9
pubmed: 26931183
Nat Genet. 2012 Jul 08;44(8):916-21
pubmed: 22772371
Am J Cardiol. 2014 Sep 15;114(6):914-20
pubmed: 25092193
Pediatr Int. 2017 Oct;59(10):1098-1100
pubmed: 28857439
Genes Dev. 1999 Sep 1;13(17):2196-206
pubmed: 10485843
Am J Hum Genet. 2012 Nov 2;91(5):950-7
pubmed: 23103230
Genes Dev. 1999 Feb 15;13(4):412-23
pubmed: 10049357
Hum Mutat. 2015 Dec;36(12):1145-9
pubmed: 26247899
J Craniofac Genet Dev Biol. 1982;2(1):65-74
pubmed: 6182156
Am J Med Genet. 1998 May 1;77(2):170-1
pubmed: 9605294
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
J Biol Chem. 1999 Dec 3;274(49):35269-77
pubmed: 10575014
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Nat Genet. 2011 Feb;43(2):121-6
pubmed: 21217753
Clin Dysmorphol. 1993 Jul;2(3):220-4
pubmed: 8287183
Clin Genet. 2016 Jun;89(6):700-7
pubmed: 26757139
Clin Genet. 2012 May;81(5):433-42
pubmed: 21564093
J Med Genet. 2010 Jul;47(7):476-85
pubmed: 20591885
J Transl Med. 2016 May 04;14(1):115
pubmed: 27146836
Genet Med. 2019 Sep;21(9):2015-2024
pubmed: 30739908
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Nat Genet. 2004 Aug;36(8):855-60
pubmed: 15235604
Nat Genet. 2005 Mar;37(3):275-81
pubmed: 15731757
Cell Res. 2009 Jan;19(1):47-57
pubmed: 19114989
Am J Hum Genet. 2014 Jul 3;95(1):113-20
pubmed: 24995870
Am J Med Genet A. 2014 Mar;164A(3):676-84
pubmed: 24357594
Proc Natl Acad Sci U S A. 2000 May 23;97(11):5924-9
pubmed: 10811875
J Am Coll Cardiol. 2015 Apr 7;65(13):1324-1336
pubmed: 25835445
Eur J Hum Genet. 2015 Feb;23(2):224-8
pubmed: 24736733
Structure. 2004 May;12(5):785-92
pubmed: 15130471
J Cell Biochem. 2012 Jun;113(6):2156-66
pubmed: 22461172
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Am J Med Genet A. 2019 Jun;179(6):936-939
pubmed: 30883014
Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3546-51
pubmed: 22334647
Hum Mutat. 2009 Jun;30(6):952-9
pubmed: 19370756
Nat Genet. 2012 Nov;44(11):1249-54
pubmed: 23023332
Am J Med Genet. 1987 Mar;26(3):599-604
pubmed: 3565476
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590

Auteurs

Pauline Arnaud (P)

Laboratory for Vascular Translational Science, INSERM U1148, Centre Hospitalo-Universitaire Xavier Bichat, 75018, Paris, France.
Département de Génétique, Centre Hospitalo-Universitaire Xavier Bichat, 46 Rue Henri Huchard, 75018, Paris, France.
UFR de Médecine, Université de Paris, 75018, Paris, France.

Caroline Racine (C)

Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'interrégion Est et FHU TRANSLAD, Hôpital d'Enfants, Centre Hospitalier Universitaire Dijon, 14, Rue Gaffarel, 21079, Dijon Cedex, France.

Nadine Hanna (N)

Laboratory for Vascular Translational Science, INSERM U1148, Centre Hospitalo-Universitaire Xavier Bichat, 75018, Paris, France.
Département de Génétique, Centre Hospitalo-Universitaire Xavier Bichat, 46 Rue Henri Huchard, 75018, Paris, France.

Julien Thevenon (J)

Unité de Génétique Clinique,Pôle Couple Enfant, CHU de Grenoble Site Nord-Hôpital Couple-Enfant, 38043, Grenoble, France.

Jean-Luc Alessandri (JL)

Service de Réanimation Néonatale, Pole Femme-Mère-Enfant, CH Felix Guyon, CHU de La Réunion, La Réunion, Saint-Denis, France.

Dominique Bonneau (D)

Département de Biochimie et Génétique et Unité Mitovasc INSERM 1083, CNRS 6015, CHU Angers, 49933, Angers, France.

Jill Clayton-Smith (J)

Manchester Centre For Genomic Medicine, St Mary's Hospital, Manchester and University Hospitals NHS Foundation Trust Manchester Academic Health Sciences Centre, Manchester, UK.
Division of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Manchester, UK.

Christine Coubes (C)

Centre de Référence Anomalies du Développement et Syndromes Malformatifs Sud-Languedoc Roussillon, Centre Hospitalier Universitaire Montpellier, Montpellier, France.

Bruno Delobel (B)

Centre de Génétique Chromosomique, GHICL, Hôpital Saint Vincent de Paul, Lille, France.

Sophie Dupuis-Girod (S)

Centre de Compétences Syndrome de Marfan et Syndromes Apparentés, Hospices Civils de Lyon, Lyon, France.

Laurent Gouya (L)

Centre de Référence Syndrome de Marfan et Pathologies Apparentés, APHP, Hôpital Bichat, Paris, France.

Sylvie Odent (S)

Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'inter-région Ouest, Service de Génétique Clinique, Univ Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes)-UMR 6290, Centre Hospitalier Universitaire Rennes, 35203, Rennes, France.

Virginie Carmignac (V)

INSERM, U1231, Génétique des Anomalies du Développement, 21079, Dijon, France.
UMR Lipides, Nutrition, Cancer, Université de Bourgogne Franche-Comté, 21000, Dijon, France.

Christel Thauvin-Robinet (C)

INSERM, U1231, Génétique des Anomalies du Développement, 21079, Dijon, France.
UMR Lipides, Nutrition, Cancer, Université de Bourgogne Franche-Comté, 21000, Dijon, France.
Centre de Référence Déficiences Intellectuelles de Causes Rares, Centre Hospitalier Universitaire Dijon, 21079, Dijon, France.

Carine Le Goff (C)

Laboratory for Vascular Translational Science, INSERM U1148, Centre Hospitalo-Universitaire Xavier Bichat, 75018, Paris, France.

Guillaume Jondeau (G)

Laboratory for Vascular Translational Science, INSERM U1148, Centre Hospitalo-Universitaire Xavier Bichat, 75018, Paris, France.
Centre de Référence Syndrome de Marfan et Pathologies Apparentés, APHP, Hôpital Bichat, Paris, France.

Catherine Boileau (C)

Laboratory for Vascular Translational Science, INSERM U1148, Centre Hospitalo-Universitaire Xavier Bichat, 75018, Paris, France. catherine.boileau@aphp.fr.
Département de Génétique, Centre Hospitalo-Universitaire Xavier Bichat, 46 Rue Henri Huchard, 75018, Paris, France. catherine.boileau@aphp.fr.
UFR de Médecine, Université de Paris, 75018, Paris, France. catherine.boileau@aphp.fr.

Laurence Faivre (L)

Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'interrégion Est et FHU TRANSLAD, Hôpital d'Enfants, Centre Hospitalier Universitaire Dijon, 14, Rue Gaffarel, 21079, Dijon Cedex, France. laurence.faivre@chu-dijon.fr.
INSERM, U1231, Génétique des Anomalies du Développement, 21079, Dijon, France. laurence.faivre@chu-dijon.fr.
UMR Lipides, Nutrition, Cancer, Université de Bourgogne Franche-Comté, 21000, Dijon, France. laurence.faivre@chu-dijon.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH